EMEA Liquid Biopsy Market Forecast 2028: Key Players and Emerging Trends

 

Future of  EMEA Liquid Biopsy Market: Key Dynamics, Size & Share Analysis

The EMEA Liquid Biopsy Market is projected to grow at a CAGR of around 13.98% during the forecast period, 2023-28. The market noticed consistent growth since the past few years, owing to the increasing prevalence of cancer patients coupled with a surge in demand for minimally invasive & fast diagnostic tests for detection. The rising prevalence of cancer has affected patients in the EMEA region, owing to the sedentary lifestyle, harmful carcinogenic elements in the environment, etc. According to the World Health Organisation (WHO), there were around 4 million cancer cases in Europe in 2020, of which nearly 2.4 million cases were in men & over 2.1 million in women.

Top Challenges Impacting the  EMEA Liquid Biopsy Market Growth

Ascending Accuracy Concerns with Rise in the Number of False Negative Results – The detection of tumor cells in the sample for the precise diagnosis requires skilled professionals as the number of ctDNA in any particular cancer mutation is low in the blood of the cancer patient, especially after any treatment or surgery, which makes the detection of ctDNA in liquid biopsy difficult. According to sampling statistics, there may be fewer detectable cancer mutations containing ctDNA in the patient’s blood sample. As a result, ctDNA was present in the sample but at a low level, and thus couldn’t be detected in the test. This affects the test result of the liquid biopsy testing for cancer by producing false negative results where ctDNA is present but not identified. False negatives can occasionally result in a tumor's recurrence not being discovered at an early stage. Therefore, these create accuracy concerns in the results, which generates doubt in clinicians & can cause impediments in the growth of the EMEA Liquid Biopsy Market.

Understanding the Core Segments in the  EMEA Liquid Biopsy Market

 EMEA Liquid Biopsy Market Size, Share & Industry Trends Analysis- By Product and Services (Equipment, Assay Kits, Services), By Circulating Biomarker (Circulating Tumour Cell (CTC), Circulating Tumour DNA (ctDNA), Cell Free DNA (cfDNA), Extracellular Vesicle (EVS)), By Technology (Multi gene analysis by Next Generation Sequencing (NGS), Single gene analysis by Polymer chase reaction (PCR)), By Sample Type (Blood Urine Others (Cerebrospinal Fluid, Plasma, Saliva, etc.)), By Application (By Cancer Application, By Non Cancer Application, By Clinical Application), By End User (Hospital and Physician laboratories, Reference Laboratories, Academic & Research Centre.

In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2026 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Unlock exclusive insights into the  EMEA Liquid Biopsy Market– request your free sample PDF now and explore key trends, growth drivers, and competitive strategies shaping the industry- https://www.marknteladvisors.com/query/request-sample/emea-liquid-biopsy-market.html 

Geographical Analysis of the  EMEA Liquid Biopsy Market

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Saudi Arabia
  • The UAE
  • Egypt
  • South Africa

Germany is expected to account for the majority of market share during the forecast period 2023-28, as the country has the highest adoption rate of liquid biopsy due to various healthcare companies such as Roche, Qiagen N.V.

Who Dominates the  EMEA Liquid Biopsy Market Insights on Key Industry Players?

Companies are strengthening their presence in the consumer electronics market by adopting strategies such as forming strategic alliances, leveraging AI, entering partnerships, pursuing mergers and acquisitions, expanding into new regions, and introducing innovative products and services.d

  • Thermofisher Scientific
  • Hoffmann-La Roche Ltd
  • Sysmex Corporation
  • Qiagen N.V.
  • Guardant Health
  • Bio Rad
  • Neo Genomics
  • Epigenomics
  • Menarini-Silicon Biosystems
  • Agena Bioscience Inc.
  • Silicon Biosystems
  • Pathway Genomics Corporation
  • Others (Myraid Genetics, Illumina Inc.,etc)

Tap into future trends and opportunities shaping the  EMEA Liquid Biopsy Market complete report: https://www.marknteladvisors.com/research-library/emea-liquid-biopsy-market.html 

Why Choose This MarkNtel Advisors Research Report

  1. Comprehensive Insights – Offers a 360° view of the market, combining qualitative and quantitative analysis for a deep understanding of trends, drivers, challenges, and opportunities.
  2. Reliable Data Sources – Data is gathered through verified primary and secondary sources, ensuring accuracy and credibility.
  3. Actionable Forecasts – Advanced predictive modeling and time-series analysis provide practical insights to guide strategic decisions and business planning.
  4. Expert Analysis – Insights from industry experts help interpret complex market dynamics, delivering clarity beyond the numbers.
  5. Customized & Strategic Reporting – The report includes detailed charts, graphs, and strategic recommendations tailored to support business growth and investment decisions.
  6. Trusted Methodology – Built on rigorous research principles, including precise sampling, data validation, and forecasting techniques, reflecting the trust businesses place in MarkNtel Advisors.

"This report equips decision-makers with actionable intelligence, enabling them to navigate market complexities with confidence and foresight."

Gain exclusive access to our comprehensive insights on the Future of  EMEA Liquid Biopsy Market. With tailored licensing options, including Mini Report Pack, Excel Data Pack, Single User, Multiuser, and Enterprise Packs, our research empowers organizations to navigate dynamic market trends effectively.

Select a License That Matches Your Business Requirements with Instant Offer -  https://www.marknteladvisors.com/pricing/emea-liquid-biopsy-market.html 

About us:

We are top leading market research company in Noida, India and have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Being one of the most efficient market research companies in India, our specialized team of experienced & efficient market research professionals is capable of grasping every minute and valuable information & data of the market to offer our clients with satisfactory details. Our company has served the biggest market research firms in India at leading positions and is proficient in managing all types of market research projects.

Trending blog:

Reach Us:

MarkNtel Advisors

Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

Contact No: +91 8719999009

Email: sales@marknteladvisors.com

Visit our Website: https://www.marknteladvisors.com

We’re always open to sharing insights, exploring ideas. Follow us to stay updated on the latest news and industry trends.


Comments

Post a Comment

Popular posts from this blog

Arthroscopy Devices Market Forecast 2028: Key Players and Emerging Trends

Image
  Future of Arthroscopy Devices Market: Key Dynamics, Size & Share Analysis The Global  Arthroscopy Devices Market  size was valued at USD 9.8 billion in 2022 and is projected to grow at around 6.8% CAGR during the forecast period, i.e., 2023-28. The increasing prevalence of joint diseases worldwide, driven by sedentary lifestyles and a lack of physical activity, especially among the geriatric population, is driving the need for minimally invasive arthroscopy surgeries globally. Moreover, as the median age of the global population continues to rise, there is a corresponding increase in the incidence of degenerative bone disorders like arthritis and osteomyelitis among individuals. Top Challenges Impacting the Arthroscopy Devices Market Growth Mounting Incidence of Trauma & Sports Injuries: Sports necessitate high-intensity physical exertion at the professional level, which can often result in player injuries. These injuries range from minor to major, requiring cli...
Read more

Lateral Flow Assay Market Forecast 2030: Key Players and Emerging Trends

Image
  Future of Lateral Flow Assay Market: Key Dynamics, Size & Share Analysis The Global  Lateral Flow Assay Market  is estimated to grow at a CAGR of around 3.4% during the forecast period, i.e., 2024-30. The market growth has been primarily attributed to the rising awareness of health and growing recommendations from healthcare professionals and major bodies such as the CDC, WHO, etc. for regular testing of various diseases. The world has witnessed incidences of epidemics and pandemics such as Ebola and COVID- 19, which have positively impacted the growth of the Lateral Flow Assay Market. Compared to other laboratory tests available, lateral flow assays that are much faster, cheaper, and user-friendly were more in demand for COVID- 19 testing. Following that, the market for Global Lateral Flow Assay has witnessed enormous growth. Top Challenges Impacting the Lateral Flow Assay Market Growth Lack of Diagnostic Efficiency of Lateral Flow Assay Tests to Hamper the Growth ...
Read more

Healthcare Simulation Market Scope and Volume Analysis with Executive Summary 2030

Image
  Future of Healthcare Simulation Market: Key Dynamics, Size & Share Analysis The Global  Healthcare Simulation Market  size is estimated to grow at a CAGR of around 15.4% during the forecast period, i.e., 2024-30. Several factors have been propelling the growth of the healthcare simulation industry in recent years. Among these, continuous technological advancements, an escalating focus on patient safety, and a burgeoning  demand for minimally invasive treatments  stood out as essential growth drivers. Further, in recent years, Minimally Invasive Surgery (MIS) has emerged as a key factor in modern healthcare, offering an alternative to traditional open surgery across diverse specialties such as laparoscopic techniques, cardiac procedures, gynecology, and orthopedics. Top Challenges Impacting the Healthcare Simulation Market Growth The Complexity of Simulating Human Functioning Poses a Challenge in the Healthcare Simulation Market – Simulating complex human t...
Read more